Giovanni Pellegrini
Overview
Explore the profile of Giovanni Pellegrini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yassini N, Sprenger J, Pastor Arroyo E, Krudewig C, Pellegrini G, Joller N, et al.
Clin Sci (Lond)
. 2023 Jul;
137(14):1013-1025.
PMID: 37431800
Ovarian cancer G protein-coupled receptor 1 (OGR1) (Gpr68) and G protein-coupled receptor 4 (GPR4) (Gpr4) are proton-activated G protein-coupled receptors that are stimulated upon increased extracellular acidity. These receptors have...
2.
Ali H, Petronijevic E, Pellegrini G, Sibilia C, Claudio Andreani L
Opt Express
. 2023 May;
31(9):14196-14211.
PMID: 37157289
Chiral properties of plasmonic metasurfaces, especially related to different absorption of left and right circularly polarized light leading to circular dichroism (CD), are a research hot topic in nanophotonics. There...
3.
Parmigiani M, Albini B, Pellegrini G, Genovesi M, De Vita L, Pallavicini P, et al.
Nanomaterials (Basel)
. 2022 Oct;
12(20).
PMID: 36296798
Surface-enhanced Raman scattering (SERS) is becoming widely used as an analytical tool, and the search for stable and highly responsive SERS substrates able to give ultralow detection of pollutants is...
4.
Petkevicius K, Palmgren H, Glover M, Ahnmark A, Andreasson A, Madeyski-Bengtson K, et al.
Nat Commun
. 2022 Oct;
13(1):6020.
PMID: 36241646
The fatty acid composition of phosphatidylethanolamine (PE) determines cellular metabolism, oxidative stress, and inflammation. However, our understanding of how cells regulate PE composition is limited. Here, we identify a genetic...
5.
La Gioia A, Chiarugi P, Fumi M, Fiorini F, Giampietro C, Michelucci E, et al.
Clin Chem Lab Med
. 2022 Aug;
60(11):e246-e249.
PMID: 36030427
No abstract available.
6.
Simmler P, Cortijo C, Koch L, Galliker P, Angori S, Bolck H, et al.
Cell Rep
. 2022 Aug;
40(8):111266.
PMID: 36001976
Mutations in the splicing factor SF3B1 are frequently occurring in various cancers and drive tumor progression through the activation of cryptic splice sites in multiple genes. Recent studies also demonstrate...
7.
Pasqualetti F, Giampietro C, Montemurro N, Giannini N, Gadducci G, Orlandi P, et al.
Genes (Basel)
. 2022 Jun;
13(6).
PMID: 35741816
. Systemic immunity and inflammation indexes (SI) derived from blood cells have gained increasing attention in clinical oncology as potential biomarkers that are associated with survival. . We tested 12...
8.
Hagen C, Roth E, Graf T, Verrey F, Graf R, Gupta A, et al.
World J Gastroenterol
. 2022 Apr;
28(10):1024-1054.
PMID: 35431492
Background: The expression of amino acid transporters is known to vary during acute pancreatitis (AP) except for LAT1 (), the expression of which remains stable. LAT1 supports cell growth by...
9.
Baumann P, Greco F, Wiegert S, Wellmann S, Pellegrini G, Cannizzaro V
J Transl Med
. 2022 Feb;
20(1):77.
PMID: 35123510
Background: Cardiovascular impairment contributes to increased mortality in preterm infants with chronic lung disease. Macitentan, an endothelin-1 receptor antagonist, has the potential to attenuate pulmonary and cardiovascular remodelling. Methods: In...
10.
Mancina R, Sasidharan K, Lindblom A, Wei Y, Ciociola E, Jamialahmadi O, et al.
Nat Metab
. 2022 Feb;
4(1):60-75.
PMID: 35102341
Fatty liver disease (FLD) is a growing health issue with burdening unmet clinical needs. FLD has a genetic component but, despite the common variants already identified, there is still a...